Hasil Pencarian  ::  Simpan CSV :: Kembali

"ABSTRAKLatar belakang: Sepsis merupakan masalah kesehatan penting yang dapat menyebabkan insidens kematian sampai 50% pada pasien dengan sepsis berat. Antibiotik aminoglikosidaterutama amikasin semakin banyak digunakan untuk mengobati infeksi kuman Gram negatif pada pasien sepsis di ICU, meskipun penggunaan obat tersebut pada dosisterapi dapat meningkatkan risiko kerusakan ginjal sekitar 10-25%. Pemantauan kadar lembah amikasin serta biomarker dini diperlukan untuk mencegah kerusakan ginjal pada pasien sepsis yang dirawat di ICU. Penelitian ini dilakukan untuk mengetahui hubungan kadar lembah amikasin pada pasien ICU dewasa yang dirawat di Rumah Sakit Cipto Mangunkusumo yang diberikan amikasin 1000 mg/hari denganpeningkatan kadar KIM-1 normalisasi dalam urin yang merupakan biomarker dini nefrotoksisitas.Metode:Penelitian ini merupakan penelitian pendahuluan yang dilakukan pada 12 pasien sepsis dewasa yang dirawat di ICU RSCM dan diberikan amikasin 1000 mg/hari pada bulan Mei-September 2015. Kadar lembah amikasin dosis ketiga dihubungkan dengan peningkatan kadar KIM-1 normalisasi yang diukur melalui urin 24 jam setelah pemberian amikasin dosis pertama/kedua dan dosis ketiga.Hasil:Dari 12 subyek penelitian, didapatkan 3 subyek penelitian dengan kadar lembah amikasin di atas 10 g/mL, sedangkan 9 subyek penelitian kadar lembahnya ada dalam batas aman (di bawah 10 g/mL). Delapan dari 12 subyek penelitian (66,7%) mengalami peningkatan kadar KIM-1 normalisasi dalam urin hari ketiga dibandingkan hari pertama. Tidak ada hubungan antara kadar lembah amikasin dengan peningkatan kadar KIM-1 normalisasi dalam urin (p=0,16; r=0,43).Kesimpulan:Pasien sepsis yang mendapat amikasin 1000 mg/hari di ICU RSCM selama 3 hari memperlihatkan kadar lembah amikasin plasma dalam batas aman untuk ginjal.

---

ABSTRACT

Background: Sepsis is a common caused of mortality which may account for up to 50% death rate in patients with severe sepsis. Aminoglycoside antibiotics, especially amikacin, are the most commonly used antibiotics in the septic patients with Gram-negative bacterial infections, despite these drugs may induce nephrotoxicity in 10-25%

patients. Hence, it is essential to monitor amikacin trough plasma concentration and to detect nephrotoxicity as early as possible. The aim of this study is to find out the correlation between amikacin trough plasma concentration with normalized KIM-1 concentration in the urine as a sensitive and specific biomarker.

Methods:

This is a pilot study conducted in 12 septic patients treated with amikacin 1000 mg/day from May, 2015 to September, 2015. The correlation between amikacin

trough plasma concentrations measured at the third doses with the elevation of urine normalized KIM-1 concentrations measured at the first/second and the third doses were evaluated.

Results:

We observed 3 patients with amikacin trough plasma concentration above the safe level (>10 g/mL), while 9 patients had amikacin concentrations within the safe

plasma level (<10 g/mL). Furthermore, we observed 8 out of 12 patients with higher normalized KIM-1 concentrations measured at third doses compared to normalized KIM-1 concentrations measured at first/second doses. There was no correlation between amikacin trough concentration with elevated urine normalized KIM-1

concentration (p=0,16; r=0,43).

Conclusion:

Septic patients treated with amikacin 1000 mg/day hospitalized in ICU RSCM for 3 days have amikacin safe trough plasma concentration."

"Latar Belakang : Kejadian AKI di unit perawatan intensif berhubungan dengan peningkatan mortalitas, morbiditas pasca AKI dan biaya perawatan tinggi. Penelitian mengenai faktor-faktor yang berhubungan dengan mortalitas pasien AKI di unit perawatan intensif di Indonesia khususnya RSUPN dr. Cipto Mangungkusumo belum pernah dilakukan.Tujuan: Mengetahui prevalensi AKI, angka mortalitas pasien AKI, dan faktor- faktor yang berhubungan dengan peningkatan mortalitas pasien AKI di unit perawatan intensif di ICU RSUPN dr. Cipto Mangunkusumo.Metode : Penelitian kohort retrospektif terhadap seluruh AKI di unit perawatan intensif di RSUPN Cipto Mangunkusumo periode Januari 2015 ndash; Desember 2016. Dilakukan analisis hubungan bivariat saampai dengan multvariat dengan STATA Statistics 15.0 antara faktor usia >60 tahun, sepsis, ventilator, durasi ventilator, dialisis, oligoanuria, dan skor APACHE II saat admisi dengan mortalitas. Hasil : Prevalensi pasien AKI di unit perawatan intensif didapatkan 12,25 675 dari 5511 subjek dan sebanyak 220 subjek 32,59 dari 675 subjek yang dianalisis meninggal di unit perawatan intensif. Faktor-faktor yang berhubungan dengan peningkatan mortalitas pada analisis multivariat adalah sepsis OR 6,174; IK95 3,116-12,233 , oligoanuria OR 4,173; IK95 2,104-8,274 , ventilator OR 3,085; IK95 1,348-7,057 , skor APACHE II saat admisi 1/2 [OR 1,597; IK95 1,154-2,209], dan durasi ventilator OR 1,062; IK95 1,012-1,114 . Simpulan : Prevalensi pasien AKI dan angka mortalitasnya di unit perawatan intensif RSUPN dr. Cipto Mangunkusumo didapatkan sebesar 12,25 dan 32,59 . Sepsis, oligoanuria, ventilator, skor APACHE II saat admisi 1/2, dan durasi ventilator merupakan faktor-faktor yang berhubungan bermakna dengan peningkatan mortalitas pasien AKI di unit perawatan intensif. Kata Kunci : Acute Kidney Injury, Faktor Risiko, Mortalitas, Unit Perawatan Intensif

---

Background Acute kidney Injury AKI in ICU associated with increased mortality rate, morbidity post AKI, and high health care cost. There is no previous study about factors associated with mortality of AKI patients in ICU in Indonesia, especially at dr. Cipto Mangunkusumo National Central General Hospital.Aim To identify prevalence, mortality rate, and factors associated with mortality of AKI patients in ICU.Method This is a retrospective cohort study. Data were obtained from all of medical records of AKI patients period January 2015 until December 2016 in ICU at Cipto Mangunkusumo hospital. Association of risk factors age 60 years old, sepsis, ventilator, duration of ventilator, oligoanuria, and APACHE II score at admission and mortality will be analyzed using STATA Statistics 15.0. Results AKI prevalence in ICU was 12,25 675 subjects from total 5511 subjects . A total of 220 subjects out of 675 subjects AKI died at ICU. Sepsis OR 6,174 95 CI 3,116 12,233 , oligoanuria OR 4,173 95 CI 2,104 8,274 , ventilator OR 3,085 95 CI 1,348 7,057 , APACHE II score at admission 1 2 OR 1,597 95 CI 1,154 2,209 , and duration of ventilator OR 1,062 95 CI 1,012 1,114 . were significant factors associated with mortality of AKI patients in ICU. Conclusion AKI prevalence and mortality rate in ICU at dr. Cipto Mangunkusumo National Central General Hospital were 12,25 and 32,59 . Sepsis, oligoanuria, ventilator, APACHE II score at admission 1 2, and duration of ventilator were significant factors associated with mortality of AKI patients in ICU. Keywords Acute Kidney Injury, Intensive Care Unit, Mortality, Risk Factor "

"Kebiasaan dalam jangka waktu yang lama akan pola diet yang tidak sehat pada masyarakat perkotaan menjadi salah satu faktor resiko terjadinya hipertensi. Penyakit ini menjadi salah satu faktor penyebab kerusakan ginjal yang dapat mengakibatkan gagal ginjal kronik. Pasien gagal ginjal kronik sering terjadi kelebihan volume cairan akibat kerusakan fungsi filtrasi glomerolus. Oleh karena itu perlu dilakukan pembatasan cairan yang ketat, efektif dan efesian untuk mencegah terjadinya komplikasi dengan upaya pemantauan intake dan output cairan. Penulisan karya ilmiah ini menggunakan metode studi kasus dengan menggunakan fluit intake output chart dan dibuktikan bahwa pemantauain ini efektif untuk menangani kelebihan volume cairan dibuktikan dengan tidak bertambahnya komplikasi yang terjadi pada pasien.

---

Long lasting habits of unhealthy diet in urban society is becoming one of hypertension risk factor. This disease has become a factor causing kidney damage, which can lead to chronic kidney failure. Chronic kidney failure patients commonly experience volume overload due to damage in glomerular filtration function. Hence, fluid restriction is needed as effective and efficient to prevent complication by monitoring fluid intake and output. This scientific writing uses case study method by using fluid intake-output chart to prove that this monitoring method is effective in handling fluid overload by looking at the occurrence of complication in patient."

"ABSTRAK Latar belakangKematian akibat sepsis dan syok septik pada pasien rawatan Intensive Care Unit (ICU) yaitu 20-30%. Pemberian antibiotik empirik yang tepat merupakan salah satu langkah awal yang sangat penting. Amikasin merupakan salah satu antibiotik terpilih untuk tata laksana sepsis di ICU RSUPN dr. Cipto Mangunkusumo (RSCM). Saat ini belum pernah dilakukan penelitian mengenai ketercapaian kadar terapi amikasin dengan menggunakan dosis standar amikasin pada pasien sepsis dewasa di ICU RSCM, sehingga studi ini menjadi penelitian pertama di Indonesia.Penelitian ini bertujuan untuk mengetahui ketercapaian kadar amikasin optimal pada pasien ICU RSCM.MetodeData dikumpulkan secara potong lintang melalui observasi terhadap hasil pemeriksaan kadar plasma amikasin, pengukuran minimum inhibitory concentration (MIC) dan perhitungan rasio Cmax/MIC pada pasien sepsis di ICU RSCM periode Mei-September tahun 2015.Hasil penelitianProporsi pasien sepsis dengan kadar amikasin optimal ialah sebesar 57% (4/7). Kadar puncak amikasin yang dapat dicapai dengan dosis 1000 mg sekali sehari tanpa menghiraukan berat badan ialah median 86,4 (43,5-238) µg/mL. Pada penelitian ini ditemukan 87% pasien dengan kadar puncak amikasin di atas 64 µg/mL, meskipun amikasin 1000 mg tersebut lebih rendah dari dosis yang dianjurkan untuk sepsis (25 mg/kgBB). Sebagian besar (78,3 %) subyek pada kenyataannya menerima dosis 15-25 mg/kgBB, dengan pemberian 1000 mg amikasin tanpa memperhatikan berat badan. Bakteri yang banyak ditemukan dari hasil kultur pasien sepsis di ICU RSCM, yaitu K. pneumoniae, A. baumanii, P. aeruginosa dan E. coli. Rentang nilai MIC untuk patogen tersebut berturut-turut yaitu 0,75 - >256 µg/mL, 0,75 - >256 µg/mL, 1,5 - >256 µg/mL dan 0,75 - 16) µg/mL. Sebanyak 84% isolat K. pneumoniae masih sensitif terhadap amikasin, diikuti oleh 63% untuk A. baumanii, 47% P. aeruginosa dan 100% untuk E. coli.KesimpulanOptimalitas amikasin terhadap bakteri Gram negatif penyebab sepsis bergantung kadar puncak dan MIC bakteri. Kadar puncak plasma amikasin yang dicapai dengan dosis 1000 mg sekali sehari sangat bervariasi. Pemberian amikasin dengan dosis per kgBB dapat dipertimbangkan. Kepekaan beberapa bakteri Gram negatif terhadap amikasin mulai menurun dengan rentang MIC yang cukup lebar. Pengukuran ketercapaian kadar optimal dalam terapi definitif dapat dilakukan untuk meningkatkan keberhasilan terapi.ABSTRACT BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment.;BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment.;BackgroundThe mortality caused by sepsis and septic shock in the Intensive Care Unit (ICU) is 20-50%. The important first step to reduce this conditions is to give the right empirical antibiotics. Amikacin is one of the antibiotics of choice for the sepsis and septic shock in ICU of Cipto Mangunkusumo (CM) Hospital. Studies on the amikacin plasma level in adult patients being given amikacin in ICU RSCM has never been done.The objective of this study is to explore the plasma level of amikacin in septic patients in CM Hospital.MethodsThis was a cross sectional study. Data on plasma amikacin level, microbiological culture, measurement of minimum inhibitory concentration (MIC), and amikacin optimal level in septic patients admitted to ICU of RSCM during May-September 2015.ResultsThe proportion of septic patients that achieve amikacin optimal level was 57% (4/7). Peak amikacin level that can be reached with 1 gram per day dose was 86,4 (43,5-238) g/mL. Although amikacin was given less than recommended dose for sepsis (25 mg/body weight), 87% patients was found to have peak amikacin level > 64 µg/mL. Most (78.3%) of the patients received amikacin with dose range 15-25 mg/kgBW, in which patients was given 1000 mg of amikacin regardless of the body weight. The organisms commonly identified from the microbiological culture septic in patients in ICU of RSCM were K. pneumoniae, A. baumanii, P. aeruginosa, and E. coli. The MIC for these pathogen were 0.75 - >256 µg/mL, 0.75 - >256 µg/mL, 1.5 - >256 µg/mL and 0.75 ? 16 µg/mL, respectively. Most (84%) of K. pneumoniae isolates was still sensitive to amikacin, while 63% A. baumanii isolate, 47% of P. aeruginosa, and 100% of E. coli were sensitive to amikacin.ConclusionsAmikacin?s efficacy to eradicate Gram negative microorganism causing sepsis depend on peak level and MIC of the microorganism. By giving 1000 mg dose per day of amikacin, highly variable peak plasma concentration of the drug was observed. Therefore, amikacin dosing based on weight might be useful to reduce the wide variation. In this study, we found that sensitivity of some Gram negative pathogen are decreasing, with wide range of MIC. Evaluation of optimal level for definitive therapy might be useful to reach more successful treatment."

"Latar Belakang : Insiden Acute Kidney Injury (AKI) pada pasien coronavirus disease 2019 (COVID-19) yang dirawat di Intensive Care Unit (ICU) yang dilaporkan dari berbagai penelitian adalah 23% sampai dengan 81% dengan mortalitas yang makin tinggi dengan semakin tingginya serum kreatinin. Terdapat perbedaan komorbiditas yang mendasari populasi yang diperiksa, serta variasi dalam praktik dan metode diagnosis dan pelaporan AKI. Evaluasi dini pemantauan fungsi hati, ginjal, serta parameter hematologi, sangat penting untuk memprediksi perkembangan COVID-19. Berdasarkan hal diatas perlu diketahui variabel apa yang dapat mempengaruhi terjadinya AKI.Tujuan : Tujuan penelitian ini adalah menganalisis insiden AKI pada pasien COVID-19 yang dirawat di ICU RSCM dan menganalisis pengaruh umur, jenis kelamin, komorbid, kreatinin, ureum, trombosit, leukosit, nilai Neutrophil Lymphocyte Ratio (NLR), C- Reactive Protein (CRP), obat vasoaktif dan obat nefrotoksik terhadap angka kejadian AKI pada pasien COVID-19 yang dirawat di ICU RSCM.Metode : Penelitian ini merupakan studi observasional retrospektif dengan desain case control study. Data yang digunakan adalah data sekunder dari rekam medis pasien COVID-19 yang dirawat di ICU RSCM. Kriteria penerimaan adalah pasien dengan usia≥ 18 tahun dan terkonfirmasi COVID-19 dengan RT-PCR positif. Kriteria penolakan adalah pasien dengan riwayat transplantasi ginjal, dan pasien Chronic Kidney Disease (CKD) gagal ginjal yang menjalani dialisis. Kriteria pengeluaran adalah pasien dengan data rekam medis yang tidak lengkap.Hasil : Dari 370 pasien yang terkonfirmasi COVID-19 yang dirawat di ICU RSCM, 152 pasien memenuhi kriteria inklusi dari 148 subjek yang direncanakan. Hasil analisis bivariat didapatkan usia, komorbid, ureum, kreatinin dan obat vasoaktif mempunyai perbedaan bermakna terhadap angka kejadian AKI. Setelah dilakukan analisis multivariat regresi logistik didapatkan komorbid (odd ratio 2,917; 95 % confidence interval, 1,377 – 6,179; p value 0,005) dan obat vasoaktif (odd ratio 2,635; 1,226 – 5,667, p value 0,013) merupakan faktor prediktor AKI pada pasien COVID-19 yang dirawat di ICU RSUPN dr. Cipto Mangunkusumo Jakarta.Kesimpulan : Insiden AKI pada pasien COVID-19 yang dirawat di ICU RSUPN Dr. Cipto Mangunkusumo Jakarta adalah 30,9%. Komorbid dan obat vasoaktif merupakan faktor prediktor AKI pada pasien COVID-19 yang dirawat di ICU RSUPN dr Cipto Mangunkusumo Jakarta.

---

Background: The incidence of Acute Kidney Injury (AKI) in COVID-19 patients treated in the Intensive Care Unit (ICU) reported from various studies is 23% to 81%, with higher mortality with higher serum creatinine. There are differences in the underlying comorbidities of the populations examined, as well as variations in practice and methods of diagnosing and reporting AKI. Early evaluation and monitoring of liver and kidney function, as well as hematological parameters, is very important to predict the development of COVID-19. By examining the predictor factors for the incidence of AKI in COVID-19 patients treated in the RSCM ICU, were there any predictor factors that were different from previous studies.

Purpose: The aim of this study was to analyze the incidence of AKI in COVID-19 patients treated at the RSCM ICU and to analyze the effect of age, gender, comorbidities, creatinine, urea, platelets, leukocytes, Neutrophil Lymphocyte Ratio (NLR), CRP, vasoactive drugs, and nephrotoxic drugs on the incidence of AKI in COVID-19 patients treated in the RSCM ICU.

Methods: This research is a retrospective observational study with a case-control study design. The data to be used is secondary data from the medical records of COVID-19 patients treated in the RSCM ICU. The acceptance criteria are patients aged ≥ 18 years and confirmed COVID-19 by positive RT-PCR. The criteria for rejection were patients with a history of kidney transplantation, and CKD patients undergoing dialysis. The exclusion criteria were patients with incomplete medical record data.

Results: Of the 370 patients with confirmed COVID-19 who were treated at the RSCM ICU, 152 patients met the inclusion criteria of the 148 planned subjects. The results of bivariate analysis showed that age, comorbidities, urea, creatinine, and vasoactive drugs had significant differences in the incidence of AKI. After multivariate logistic regression analysis, we found comorbid (OR 2.917; 95% CI, 1.377 – 6.179; p value 0.005) and vasoactive drugs (OR 2.635; 1.226 – 5.667, p value 0.013) is a predictor factor for AKI in COVID-19 patients treated at the ICU RSUPN Dr. Cipto Mangunkusumo Jakarta.

Conclusion: Incidence of AKI in COVID-19 patients treated at ICU RSUPN Dr. Cipto Mangunkusumo Jakarta is 30.9%. Co-morbidities and vasoactive drugs are predictors of AKI in COVID-19 patients treated at the ICU RSUPN Dr. Cipto Mangunkusumo Jakarta."

"Tujuan: Mengetahui korelasi antara kadar sang (Zn) plasma dengan jumlah Iimfosit CD4 penderita HIV/AIDS.Tempat: Poliklinik Kelompok Studi Khusus (Pokdisus) AIDS Fakultas Kedokteran Universitas Indonesia/RSUPN Dr. Cipto Mangunkusumo, Jakarta.Metodologi: Penelitian potong lintang dilakukan pada 52 orang penderita HIV/AIDS. Wawancara dilakukan pada subyek penelitian untuk mendapatkan data demografi, infeksi oportunistik, asupan energi dan asupan Zn. Data asupan energi didapatkan dengan metode food recall 1x24 jam, sedangkan data asupan Zn didapatkan dengan menggunakan metode FFQ semikuantitatif selama satu bulan terakhir. Status gizi ditentukan berdasarkan IMT. Pemeriksaan laboratorium yang dilakukan meliputi pemeriksaan kadar Zn plasma dan jumlah limfosit CD4. Untuk mengetahui korelasi dipergunakan uji korelasi Pearson dan Spearman-Rank.Hasil: Subyek penelitian terdiri dari 44 orang laki-laki dan delapan orang perempuan, terbanyak berada pada rentang usia 20-29 tahun (80,8%), dengan rerata usia 26,4613,60 tahun, 75% berpendidikan sedang, 63,5% berada di bawab upah minimum propinsi (UMP), Rerata IMT 19,5512,83 kg/m2, 53,8% subyek termasuk kriteria berat badan normal. Nilai rerata asupan energi subyek adalah 1574,11 ± 198,48 kkal/hari, 82,7% subyek mempunyai asupan energi kurang. Rerata asupan Zn 6,9810,92 mglhari, dan 94,2% subyek mempunyai asupan Zn kurang. Median kadar Zn plasma 13,63 (11,26-44,98) µmol/L, 17,3% subyek mengalami defisiensi Zn. Median jumlah limfosit CD4 81 (2-747)/µL., 75% subyek mernpunyai jumlah Iirfosit CD4 < 200/µL. Sebagian besar (80,8%) subyek mengalami infeksi oportunistik, berdasarkan pola infeksi oportunistik, terbanyak adalah kandidiasis orofaring (55,8%). Didapatkan korelasi bermakna antara kadar Zn plasma dengan jumlah limfosit CD4 (r=0,29;p=0,04), dan korelasi tidak bermakna antara asupan Zn dengan kadar Zn plasma (r=0,07; p=0,65) serta antara status gizi (IMT) dengan jumlah limfosit CD4 (r=0,2 I ; p=1,13).Kesimpulan: Didapatkan korelasi bermakna antara kadar Zn plasma dengan jumlah Iimfosit CD4 (r=0,29; p=0,04)

---

Objective: To investigate the correlation between plasma zinc (Zn) concentration and the number of CD4 lymphocytes count in HIV/AIDS patients

Methods: This was a cross sectional study of 521-I1V/AIDS patients. Interviews were done to get data about demographic characteristics, opportunistic infections, energi intake and Zn intake. The daily energy intake was assessed using 24h food recall method, while dietary Zn intake was assessed by using semiquantitative FFQ method. Nutritional status was determined BM1. Laboratory examination was done to assess plasma Zn concentration and CD4 lymphocytes count. Pearson's and Spearman's-Rank correlation tests were used to determine the correlation.

Subjects: consisted of forty four (84,6%) males and eight (19,2%) females, most of the subjects were in the 20-29 years old range (80,8%), with mean age of 26,46+3,60 years. Most subjects (75%) had medium education level and 33 subjects (63,5%) were earning under LIMP. Mean value of BMI was 19,55+2,83 kglm2 and based on the BMI levels, most of the subjects were normal (53,8%). Mean daily energy intake were 1574,11 ± 198,48 kcal, 82,7% had Iow energy intake. Mean Zn intake was 6,98 ± 0,92 mg/day, and 94,2% had low Zn intake_ Median plasma Zn concentration was 13,63 (11,26 - 44,98) /µL and 17,3% of subjects had low plasma Zn concentration. Median of CD4 lymphocytes count was 81 (2-747)//µL, 75% subjects had CD4 lymphocytes count < 200//µL, 80,8% subjects had opportunistic infections, and the most prevalent was oesophageal-orofaryng candidiasis (55,8%). There was a significant correlation between Zn plasma level and CD4 lymphocytes count r=0,29; p = 0,04). No significant correlation were found between Zn intake and plasma Zn concentration (r=0,07; p=0,65) and between BMI and CD4 lymphocytes count (r=0,21; p=0,13).

Conclusion: There was significant correlation between Zn plasma level and CD4 lymphocytes count (r = 0,29; p = 0,04)."

"Chronic kidney disease (CKD) yang prevalensinya meningkat dalam beberapa tahun terakhir, seringkali berdampak pada penurunan sensasi, edema, anemia, hingga penurunan kesadaran atau koma. Kondisi-kondisi tersebut meningkatkan risiko terjadinya pressure ulcer. Selain merugikan bagi health outcome pasien, kejadian pressure ulcer juga memberikan dampak negatif dari aspek costeffectivenes dan mutu pelayanan rumah sakit. Oleh karena itu, diperlukan upaya pencegahan terjadinya pressure ulcer, salah satunya dengan penerapan topikal ekstra virgin olive oil (EVOO) pada area-area yang berisiko tinggi pressure ulcer. Penulisan ini bertujuan untuk menggambarkan penerapan EVOO untuk mencegah pressure ulcer, khususnya pada area sakrum, regio trokanter, dan tumit. Pada karya ilmiah ini, pasien dirawat selama enam hari. Hasil pengkajian menunjukan pasien berisiko tinggi mengalami risiko gangguan integritas kulit dengan faktor risiko adanya edema, anemia, ketidakseimbangan cairan dan elektrolit, penurunan sensasi, dan imobilitas. Intervensi keperawatan yang dilakukan antara lain, evaluasi berkala integritas kulit dan reposisi dua jam sekali. Selain itu, diaplikasikan juga EVOO sebanyak dua kali sehari selama lima hari dan dilakukan setiap kali pengaplikasian. Hasil evaluasi pressure ulcer mampu dicegah pada sebagian besar area yang diintervensi, sehingga penerapan EVOO secara topikal dapat menjadi salah satu pilihan bagi perawat sebagai intervensi keperawatan mandiri untuk mencegah terjadinya pressure ulcer.

---

Chronic kidney disease (CKD), whose prevalence has increased in recent years, often results in decreased sensation, edema, anemia, and loss of consciousness or coma. These conditions increase the risk of pressure ulcers. In addition to being detrimental to the health outcomes of patients, the incidence of pressure ulcers also has a negative impact from the aspects of cost-effectivenes and quality of hospital services. Therefore, efforts are needed to prevent the occurrence of pressure ulcers, one of which is by applying topical extra virgin olive oil (EVOO) to areas at high risk of pressure ulcers. This paper aims to describe the effectiveness of EVOO application to prevent pressure ulcers, especially in the sacrum area, trochanter region, and heel. In this scientific work, the patient was treated for six days. Assessment results showed that the patient was at high risk of skin integrity impairment with risk factors for edema, anemia, fluid and electrolyte imbalance, decreased sensation, and immobility, electrolytes, decreased sensation, and immobility. Nursing interventions that carried out include periodic evaluation of skin integrity and repositioning every two hours. In addition, EVOO was also applied twice a day for five days and done every time the five days and was done every time the application was done. The evaluation results showed that pressure ulcers prevented in most of the intervened areas, so topical application of EVOO can be an option for nurses as an independent nursing intervention to prevent pressure ulcers."

"Latar Belakang: Gangguan ginjal akut sering terjadi pada penderita sirosis hati dan berhubungan dengan meningkatnya mortalitas. Model prediksi terjadinya gangguan ginjal akut yang dapat dihitung saat masuk perawatan diharapkan dapat mnemukan pasien yang memiliki resiko dehingga dapat dilakukan upaya mencegah terjadinya gangguan ginjal akut.Tujuan: Penelitian ini dilakukan untuk mengetahui hubungan antara perdarahan saluran cerna, riwayat parasintesis besar, skor MELD, sepsis, peritonitis bakterial spontan, kadar albumin serum, kadar hemoglobin dan rasio netrofil terhadap limfosit dengan terjadinya gangguan ginjal akut pada pasien sirosis hati dan membuat suatu model prediksi terjadinya gangguan ginjal akut pada pasien sirosis hati.Metode: : Analisis data dilakukan terhadap 209 pasien sirosis hari yang dirawat inap di RSUPN Cipto Mangunkusumo dari tanggal 1 January 2019 hingga 31 December 2019. Gangguan ginjal akut didefenisikan dengan terjadinya peningkatan kadar kreatinin serum ≥ 0.3 mg/dL dalam 48 perawatan.Hasil: Terdapat 45 pasien (21,5%) mengalami gangguan ginjal akut.. rasio netrofil terhadap limfosit (p<0.001), skor MELD (p<0.001) and kadar albumin serum (p<0.001) berhubungan dengan terjadinya gangguan ginjal akut. Rasio netrofil limfosi lebih dari 8 (nilai prediksi 2), kadar bilirubin total serum lebih dari 1,9 (nilai prediksi 2) dan kadar albumin serum kurang dari 3(nilai prediksi 1) merupakan nilai batas untuk prediksi. Skor prediksi ≥4 dapat menjadi prediktor terjadinya gangguan ginjal akut pada pasien sirosis hati dengan sensitifitas 97,3%.Simpulan: Rasio netrofil terhadap limfosit, skor MELD, kadar albumin serum berhubungan dengan terjadinya gangguan ginjal akut pada penderita sirosis hati yang dirawat inap.Suatu sistem skor dengan menggunakan rasio netrofil terhadap limfosit, kadar bilirubin total serum dan kadar albumin serum merupakan prediktor yang dapat digunakan untuk prediksi terjadinya gangguan ginjal akut ini.

---

Background : Development of acute kidney injury (AKI) is common and is associated with poor outcomes. A risk prediction score combining values easily measured at admission could be valuable to stratify patients for prevention, monitoring and early intervention, ultimately improving patient care and outcomes.

Objective: This study aimed to determine association of gastrointestinal bleeding history, large paracentesis history, MELD score, sepsis, spontaneous bacterial peritonitis, serum albumin level, hemoglobin level and netrophyl lymphocyte ratio for development of acute kidney injury in cirrhosis patients and to know the prediction score for the development of AKI in hospitalized cirrhosis patients

Methods: A cross-examined the data from a retrospective analysis of 209 patients with cirrhosis admitted to the Cipto Mangunkusumo Hospital from January 2019 to December 2019. AKI was defined as an increase in serum creatinine ≥0.3 mg/dL within 48 hours from baseline. A receiver operating characteristic (ROC) curve was produced to assess the discriminative ability of the variables. Cutoff values were defined as those with highest validity. The final AKI risk score model was assessed using the ROC curve.

Results: A total of 45 patients (21,5%) developed AKI. Higher NLR (p<0.001), Model of End-stage Liver Disease (MELD) (p<0.001) and lower serum albumin level (p<0.001) were independently associated with AKI. Finding the prediction score of acute kidney injury, cut off values with the highest validity for predicting AKI were determined and defined as 8 for the neutrophil lymphocyte ratio, 1,9 for total bilirubine serum and 3 for serum albumin level. The risk score was created allowing 2 points if the netrophyl lymphocyte ratio is higher than 8, 2 point if the serum total bilirubine is higher than 1,9 and 1 point if the serum albumin is lower than 3. The AUROC curve of the risk prediction score for AKI was 0.842. A risk score of ≥4 points predicts AKI in cirrhotic patients with a sensitivity of 97,3%.

Conclusions: The netrophyl lymphocyte ratio, MELD score and albumin level are associated with the development of AKI in hospitalized cirrhosis patients. A score combining netrophyl lymphocyte ratio, serum bilirubin and albumin level demonstrated a strong discriminative ability to predict AKI in hospitalized cirrhotic patients"

"ABSTRAKNama : Imam Kurniawan RizalProgram Studi : Ilmu KeperawatanJudul : Analisis Massase dengan Menggunakan VCO Pada Pasien Chronic Kidney Disease CKD dengan Penurunan Kesadaran Di Ruang Anak, Lantai 1 Gedung A, RSUP Cipto Mangunkusumo Luka tekan merupakan kerusakan integritas kulit yang mengalami tekanan berkepanjangan dan terus menerus. Luka tekan berada di peringkat ketiga yang membutuhkan biaya perawatan besar dan penyebab kematian tertinggi. Dalam mengantisipasi semakin tinggi angka kematian yang diakibatkan oleh luka tekan, perawat harus lebih sadar dan memberikan perhatian khusus untuk menangani masalah ini. Salah satu upaya pencegahan luka tekan dapat dilakukan dengan massase menggunakan VCO. Karya Ilmiah Akhir Ners ini bertujuan untuk menganalisis intervensi massase dengan menggunakan VCO untuk mencegah terjadi luka tekan pada pasien CKD dengan penurunan kesadaran. Metodologi yang digunakan adalah metode studi kasus dan analisa penelitian yang telah ada. Hasil analisa yang didapat menunjukkan bahwa intervensi ini terbukti efektif karena dapat mencegah luka tekan dengan tanda tidak terjadi kemerahan pada kulit pasien. Kata kunci: Virgin Coconut Oil, Luka tekan, Massase

---

ABSTRACTName Imam Kurniawan RizalStudy program NursingTitle Massage Analysis Using VCO in Chronic Kidney Disease CKD Patients With Decreased Awareness in Child Room, 1st Floor of Building A, RSUP Cipto Mangunkusumo Pressure ulcers is a malfunction integrity skin because have pressure prolonged and continuous. Pressure ulcers is ranked third which requires the greatest care costs and the highest cause of death. In anticipation of the higher mortality caused by the pressure ulcers, the nurse must be more aware and pay special attention to handle this problem. One of prevention pressure ulcers can be done by massase using Virgin Coconut Oil VCO . This Final Scientific Work of Ners aims to analyze the interventions of massase by using Virgin Coconut Oil VCO to prevent pressure ulcers on patients Chronic Kidney Disease CKD with impairment of consciousness. The methodology used is the case study method and the existing research analysis. The results obtained showed this intervention proved to be effective as it can prevent pressure ulcers with no signs of redness on the patients skin. Keyword Virgin Coconut Oil, Pressure ulcers, Massage "

"Penyakit ginjal kronik merupakan penyakit kronik yang bersifat irreversible dan progresif yang disebabkan oleh kerusakan vaskular seperti pada hipertensi dan diabetes mellitus. Kerusakan vaskular pada penyakit ginjal kronik dapat menyebabkan masalah kelebihan volume cairan tubuh yang dapat mengakibatkan komplikasi sistemik. Penulisan karya ilmiah ini menggunakan studi kasus dengan tujuan menganalisis intervensi pemantauan cairan pasien penyakit ginjal kronik dengan menggunakan lembar pemantauan intake dan output. Intervensi pemantauan cairan dilakukan selama 5 hari di ruang rawat gedung A lantai 7 zona A RSUPN. Dr. Ciptomangun Kusumo Jakarta. Rekomendasi dari kasus ini adalah penggunaan lembar pemantauan pada pasien yang beresiko mengalami ketidakseimbangan cairan seperti pada pasien penyakit ginjal kronik. Sehingga intervensi penggunaan lembar pemantauan efektif untuk mengatasi kelebihan volume cairan.

---

Chronic kidney disease is  a chronic, irreversible, and progressive disease resulting from vascular impairment such that occurs in hypertension and diabetes mellitus condition. Vascular impairment in chronic kidney disease may result in excess fluid volume which leads to systemic complications. The study design was case study and aimed to analyze fluid monitoring intervention in patient with chronic kidney disease by employing intake and output monitoring sheet. The intervention was conducted in Zone A ward of 7th floor Building A of RSUPN Dr. Cipto Mangunkusumo for 5 days long. The study recommends the use of fluid monitoring sheet in patient with risk for fluid imbalance such as in chronic kidney disease. Therefore, use of intake and output monitoring sheet is effective in managing excess fluid volume."